Rapid extraction, radioiodination, and in vivo catabolism of 125I-labeled fibrinogen in the horse.

This research study analyses two methods for successfully extracting horse fibrinogen from fresh plasma and then radiolabeling it with 125I. The average clottable radioactivity was found to be 94.1% and the protein-bound activity was 98.5%. When the radiolabeled fibrinogen was administered intravenously to 15 horses, it was found to have a mean plasma half-life of approximately 5 days.

Fibrinogen Extraction Methods

• The research studied two distinct methods for the extraction of horse fibrinogen from fresh plasma.
• For both methods, the scientists utilized an ammonium sulphate-sodium phosphate buffer to carry out the extraction process.
• The effectiveness of these two different methods in successfully extracting equine fibrinogen became the core of their comparative analysis.

Radioiodination of Fibrinogen

• After the successful extraction of the fibrinogen, the researchers proceeded to radiolabel the fibrinogen using the isotope 125I.
• A monochloroiodine reagent was used during this process.
• 125I was utilized due to its long half-life of 60.2 days, and its gamma decay energy of 35 keV.

Protein-bound Activity and Clottable Radioactivity

• The researchers found a significantly high protein-bound activity and clottable radioactivity after the fibrinogen had been radiolabeled.
• 98.5% of the fibrinogen was protein-bound, meaning it was successfully linked to the 125I isotope.
• Meanwhile, 94.1% of the fibrinogen was clottable, indicating that the radiolabeled fibrinogen was mostly capable of forming blood clots.

In-vivo Catabolism of Radiolabeled Fibrinogen

• In the final phase of the study, the radiolabeled fibrinogen was administered intravenously to 15 horses.
• The half-life of the administered fibrinogen in the plasma of the horses was found to be around 5 days on average, indicating the timespan for the concentration of fibrinogen to reduce by half in the body.

Conclusion of the Study

Based on the findings, the research concluded that there are effective methods for extracting fibrinogen from horse plasma and radiolabeling it with 125I. This lays groundwork for future studies related to the function, behavior, and presence of fibrinogen in the equine body. It could also be applied to other studies regarding blood clotting and related mechanisms in horses.